Prefer Divis Laboratories: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "I like Divis Laboratories. The stock is making lifetime new highs consistently and that is a place where one can still enter and hope for some profits. Biocon has completed a correction and is renewing its upmove."

At 13:14 hrs Biocon was quoting at Rs 457.55, down Rs 0.20, or 0.04 percent. It has touched an intraday high of Rs 462 and an intraday low of Rs 456.

The share touched its 52-week high Rs 497.40 and 52-week low Rs 272.50 on 22 January, 2014 and 13 June, 2013, respectively. Currently, it is trading 8.01 percent below its 52-week high and 67.91 percent above its 52-week low. Market capitalisation stands at Rs 9,151 crore.

Disclosure: Analyst does not have positions in the stocks.